Minimal Change Disease (Pediatric Nephrotic Syndrome)
Glomerular Podocyte Barrier Dysfunction Syndrome
Primary risk age: 2 to 7 Years (Accounts for over 85% of childhood nephrotic cases)
- Urgency
- Severe
- Typical age
- 2 to 7 Years (Accounts for over 85% of childhood nephrotic cases)
- Body system
- Renal & Urological
Typical course: Proteinuria typically resolves within 7 to 14 days of starting steroids; the full initial course of steroid therapy spans 8 to 12 weeks.
Reviewed against AAP · CDC · WHO · NHS guidance Last reviewed 2026-06-13
1. Summary & Pathophysiology
Glomerular Podocyte Barrier Dysfunction Syndrome
Pathophysiology (Development Path)
The unclassified circulating cytokine causes the effacement (flattening) of podocyte foot processes in the glomerulus. This disrupts the negative charge barrier of the glomerular basement membrane, allowing large amounts of serum albumin to leak into the urine. The resulting heavy proteinuria leads to hypoalbuminemia, which drops plasma oncotic pressure and causes fluid to shift into the interstitial spaces, driving widespread edema.
Primary Causes & Etiology
Idiopathic etiology; believed to involve T-cell dysregulation that leads to the production of a circulating permeability factor, which damages the glomerular capillary wall.
2. Symptom Continuum
- Early Onset Signs
Periorbital edema (puffiness around the eyes), often noticed first in the morning and mistaken for allergic reactions.
- Progressive Phase
Pitting dependent edema spreading to the ankles, feet, and labia or scrotum, along with a noticeable reduction in urine output and frothy or foamy urine.
- Severe Indicators
Generalized fluid overload (anasarca), significant ascites causing abdominal pain and respiratory discomfort, respiratory distress from pleural effusions, and signs of intravascular volume depletion.
3. Clinical Verification
Urinalysis showing heavy proteinuria (3+ or 4+), a 24-hour urine protein collection exceeding 40 mg/m²/hour, serum labs revealing hypoalbuminemia (<2.5 g/dL), and hyperlipidemia.
4. Care & Elements Plan
Primary Care Treatment Plan
Induce clinical remission using a standardized course of systemic corticosteroids. Manage fluid balance carefully with dietary sodium restrictions and targeted diuretic therapy if fluid overload compromises breathing.
Home Support Elements
Monitor daily weights using the same scale first thing in the morning. Use urine dipsticks at home to track protein levels and monitor for early signs of a relapse.
Generic Active Ingredients (No Brands)
- Prednisone (systemic corticosteroid active ingredient used to restore podocyte integrity)
- Furosemide (loop diuretic active ingredient used to manage severe edema under clinical supervision).
Lists active elements only. Never administer self-designed therapies.
5. Doctor Critical Lines
Critical Thresholds: When to See a Doctor
Seek prompt evaluation if a child develops swelling around the eyes or extremities, has a significant decrease in urine output, or shows signs of an active infection while taking steroids.
6. Vaccine & Prevention
Routine Prophylaxis (Prevention)
No preventative methods exist, as the underlying immunological trigger remains unclassified.
Immunization Context
Avoid live viral vaccines (such as MMR and Varicella) while the child is on high-dose immunosuppressive corticosteroid therapy.
7. Timelines & Outlook
Active Timeline
Proteinuria typically resolves within 7 to 14 days of starting steroids; the full initial course of steroid therapy spans 8 to 12 weeks.
Expected Prognosis
Excellent response rate; over 90% of children achieve complete remission with steroid therapy, though a significant portion may experience subsequent relapses during childhood.
Potential Untreated Complications
Severe bacterial infections (such as spontaneous bacterial peritonitis from Streptococcus pneumoniae due to immunoglobulin loss), thromboembolism, and hypervolemic shock.
More in Glomerular Boundary Filtration Pathology
Severe Acute Post-Streptococcal Glomerulonephritis (APSGN)
Post-Streptococcal Immune Complex Glomerulopathy
5 to 12 Years (Rare under 3 years)
Emergency Hemolytic Uremic Syndrome (HUS)
Serious condition combining red-cell destruction, low platelets, and acute kidney injury.
Most common in children under 5 years.